AzTrials
AzTrials

Colorectal SurgeryNCT06662799

Dorsal Vetilation and PPCs in Colorectal Cancer Surgery Patients

An observational study of Colorectal Surgery and Postoperative Pulmonary Complications (PPCs), run by First Affiliated Hospital of Zhejiang University at 1 site in China.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Postoperative pulmonary complications (PPCs) are common in patients after major abdominal surgery. It has been shown that 5-40% of patients occur PPCs after major surgery, and the mid to high PPC rate is observed after laparoscopic colorectal cancer surgery. Read more about this study

Who is it for?
Ages 18 years and older
How many people
92 participants
Where
1 siteChina
Study dates
1 Jul 2024to 25 Dec 2024
How long will I take part?
10 Days
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: Patients undergoing laparoscopic colorectal cancer surgery

Who may be able to join

  • Age ≥18 years
  • ASA grade I-III
  • The patients who are planning to undergo laparoscopic colorectal cancer surgery

Who cannot join

  • Emergency surgery
  • Time of surgery less than 2 hours
  • Preoperatively present upper respiratory tract infection or acute pulmonary infection
  • Previous history of pulmonary surgery
  • Preoperative use of home ventilator
  • Inability to perform EIT monitoring
  • Declined to participate in this study

Trial locations and contacts

1 site in 1 country.

China1 site
  • The first Affiliated Hospital, School of Medicine, Zhejiang University.

    Hangzhou, Zhejiang, 310000

Other trials in China

About this study

Official title: Intraoperative Reduction of Ventilation of Dorsal Lung Regions and Postoperative Pulmonary Complications After Laparoscopic Colorectal Cancer Surgery

Postoperative pulmonary complications (PPCs) are common in patients after major abdominal surgery. It has been shown that 5-40% of patients occur PPCs after major surgery, and the mid to high PPC rate is observed after laparoscopic colorectal cancer surgery. PPCs are associated with poor clinical outcomes including prolonged hospital length of stay and increased morbidity and mortality.

Mechanical ventilation during general anesthesia can lead to a redistribution of ventilation, increase the aereation in the ventral parts of the lung, whereas reduce ventilation in the dorsal parts of the lung compared with spontaneous breathing (SB) in the awake state in supine position. The reduction of ventilation of dorsal lung regions indicates the presence of dorsal atelectasis during mechanical ventilation after general anesthesia, which may be associated with PPCs. However, there is still no evidence to reveal the association between the reduction of dorsal ventilation and PPCs.

Read more

Recently, electrical impedance tomography (EIT), which allows visualization of lung ventilation in real time, and assessment of regional lung ventilation. It is feasible to assess the change of ventral/dorsal lung ventilation during the surgery using EIT. To date, no study has investigated whether the change of ventral/dorsal lung ventilation revealed by EIT could be associated with PPCs.

So, this prospective observational study aims to clarify whether patients developing postoperative pulmonary complications had higher reduction of dorsal lung ventilation during operation after general anesthesia as compared to patients not developing postoperative pulmonary complications. Ratio of dorsal ventilation during spontaneous respiration (T0) in the awake state as a reference, the proportion of dorsal ventilation after anesthesia induction and endotracheal intubation (T1), body position change and capnoperitoneum (T2), and at the end of surgery (T3) were analyzed. Thereafter, evaluating the change of dorsal ventilation in patients with PPCs and without PPCs at different time points.

According to the method of sample size calculation published by Scaramuzzo G et al. (Anesthesiology. 2024 Oct 1;141(4):693-706.). A minimum sample size required for this study was calculated as following: using the difference of reduction of dorsal ventilation at the end of surgery between the patients with PPCs and non-PPCs as the primary outcome. Considering the data of our preliminary experiment showed that a reduction of dorsal lung ventilation at the end of surgery is 12 ± 6% and hypothesizing 30% of patients experiencing postoperative pulmonary complications and a relative clinically relevant increase in reduction of dorsal lung ventilation of 40% in those with postoperative pulmonary complications, we found that 83 patients were sufficient to evaluate differences between groups (effect size 0.8) with a power of 0.90 and an α error of 0.05. Considering a dropout of 10%, we found a minimum sample size of 92 patients.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. The difference of reduction of dorsal ventilation at the end of surgery between the patients with PPCs and non-PPCs

    1. EIT to monitor the regional ventilation of the patients at spontaneous breathing (SB) in the awake state in supine position (T0) and the end of surgery (T3). The reduction of the ratio of dorsal ventilation will be caculated between T3 and T0.
    2. Follow-up the patients untill discharge from the hostiptal. Based on whether pulmonary complication occurs during 7 days after surgery, the participants will be divided into the patients with PPCs and the patients with non-PPCs.
    3. The difference of reduction of dorsal ventilation at the end of surgery (T3) between the patients with PPCs and non-PPCs will be analyzed.

    Measured: 1-7 days after surgery.

Secondary outcomes (3)
  1. The difference of reduction of dorsal ventilation at endotracheal intubation after general anesthesia induction between the patients with PPCs and non-PPCs

    EIT to monitor the regional ventilation of the patients at spontaneous breathing (SB) in the awake state in supine position (T0) and endotracheal intubation after general anesthesia induction (T1). The reduction of the ratio of dorsal ventilation will be caculated between T1 and T0. 2. Follow-up the patients untill discharge from the hostiptal. Based on whether pulmonary complication occurs during 7 days after surgery, the participants will be divided into the patients with PPCs and the patients with non-PPCs. 3. The difference of reduction of dorsal ventilation at endotracheal intubation after general anesthesia induction (T1) between the patients with PPCs and non-PPCs will be analyzed.

    Measured: 1-7 days after surgery.

  2. The difference of reduction of dorsal ventilation at pneumoperitoneum and body position change between the patients with PPCs and non-PPCs

    EIT to monitor the regional ventilation of the patients at spontaneous breathing (SB) in the awake state in supine position (T0) and pneumoperitoneum and body position change (T2). The reduction of the ratio of dorsal ventilation will be caculated between T2 and T0. 2. Follow-up the patients untill discharge from the hostiptal. Based on whether pulmonary complication occurs during 7 days after surgery, the participants will be divided into the patients with PPCs and the patients with non-PPCs. 3. The difference of reduction of dorsal ventilation at pneumoperitoneum and body position change (T2) between the patients with PPCs and non-PPCs will be analyzed.

    Measured: 1-7 days after surgery.

  3. The risk factors which are associated with PPCs

    1. Collecting age, gender, height, weight, history of chronic diseases such as hypertension and chronic obstructive pulmonary disease (COPD) etal, and assessing the pre-operative respiratory risk of patients using the ARISCAT (Assess Respiratory Risk in Surgical Patients in Catalonia) scoring system developed by Canet J et al.
    2. To explore the independent risk factors which are associated with PPCs using logistic regression.

    Measured: 1-7 days after surgery.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted29 Oct 2024
  2. Study start1 Jul 2024
  3. Primary completion15 Dec 2024
  4. Study completion25 Dec 2024

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
92 participants (actual)
Target duration
10 Days
IDs, dates and publications
ClinicalTrials.gov ID
NCT06662799
Sponsor's protocol ID
IIT20240443B
Status last verified
Dec 2024
First submitted
7 Oct 2024
Last updated
3 Jan 2025
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No

Publications

  • Wu S, Cui P, Wang B, Shui W, Chu L, Fang X, Xie G. Intraoperative dorsal lung ventilation reduction and postoperative pulmonary complications after laparoscopic colorectal cancer surgery: A prospective cohort study. Chin Med J (Engl). 2026 Aug 14. doi: 10.1097/CM9.0000000000004197. Online ahead of print.

    PubMed 42604997

Questions about this trial

What is this clinical trial studying?

An observational study of Colorectal Surgery and Postoperative Pulmonary Complications (PPCs), run by First Affiliated Hospital of Zhejiang University at 1 site in China.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 3 Jan 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in China. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

The difference of reduction of dorsal ventilation at the end of surgery between the patients with PPCs and non-PPCs (time frame: 1-7 days after surgery.). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT06662799, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 3 Jan 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in